Table 2 Definition of generic medicines
From: “No generics, Doctor!” The perspective of general practitioners in two French regions
N | % | 95% CI | |
|---|---|---|---|
How would you define generic medicines? (Several possible responses) | |||
Same active substance as the originator | 246 | 77.8 | 74.7–80.7 |
More economical | 80 | 25.3 | 22.3–28.6 |
Different excipients | 68 | 21.5 | 18.7–24.6 |
Poor-quality copy | 35 | 11.1 | 9.0–13.6 |
Off-patent | 34 | 10.8 | 8.7–13.2 |
Equivalent to the originator | 34 | 10.8 | 8.7–13.2 |
Different presentation | 18 | 5.7 | 4.2–7.6 |
Produced by a different laboratory than the originator | 17 | 5.4 | 4.0–7.3 |
Efficacy equivalent to the originator | 13 | 4.1 | 2.9–5.8 |
Name conforms with the INNa | 10 | 3.2 | 2.1–4.7 |
Identical quality to the originator | 2 | 0.6 | 0.3–1.6 |
Bioequivalent to the originator | 1 | 0.3 | 0.0–1.1 |
Safety equivalent to the originator | 0 | 0 | 0 |